Award details

Anticoccidial vaccine development: the importance of genetic diversity and delivery strategy

ReferenceBBS/E/I/00001485
Principal Investigator / Supervisor Professor Fiona Tomley
Co-Investigators /
Co-Supervisors
Institution The Pirbright Institute
DepartmentThe Pirbright Institute Department
Funding typeResearch
Value (£) 29,700
StatusCompleted
TypeInstitute Project
Start date 27/09/2010
End date 25/10/2010
Duration1 months

Abstract

Coccidiosis is a devastating disease of poultry and other livestock caused by protozoan parasites of the genus Eimeria. Cost-effective, multi-valent recombinant vaccines are a realistic prospect following the identification of immunoprotective parasite antigens and development of parasite transfection technologies. To predict the likely efficacy and longevity of such vaccines in the field it is important to know the prevalence of naturally-occurring genetic (antigenic) diversity, rate of multiple infections, and frequency of genetic exchange between parasites. It is crucial also to have strong geographical networks in place, both for collecting parasites for the laboratory studies outlined above and to ensure efficient dissemination, delivery and support of traditional and new therapeutics (drugs and vaccines) to the world's poorest rural economies.

Summary

unavailable
Committee Not funded via Committee
Research TopicsAnimal Health, Immunology, Microbiology
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file